Leerink Partnrs Has Optimistic Outlook of THC Q2 Earnings

Tenet Healthcare Co. (NYSE:THC - Free Report) - Analysts at Leerink Partnrs lifted their Q2 2025 earnings per share estimates for Tenet Healthcare in a research report issued to clients and investors on Thursday, April 24th. Leerink Partnrs analyst W. Mayo now expects that the company will earn $2.62 per share for the quarter, up from their prior estimate of $2.60. The consensus estimate for Tenet Healthcare's current full-year earnings is $12.24 per share. Leerink Partnrs also issued estimates for Tenet Healthcare's Q3 2025 earnings at $2.75 EPS, Q4 2025 earnings at $3.47 EPS and FY2027 earnings at $15.92 EPS.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $4.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.11 by $1.25. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. The company had revenue of $5.22 billion for the quarter, compared to analysts' expectations of $5.15 billion. During the same quarter in the prior year, the firm earned $3.22 earnings per share. Tenet Healthcare's revenue was down 2.5% compared to the same quarter last year.

Other analysts have also recently issued research reports about the company. TD Cowen started coverage on Tenet Healthcare in a research report on Wednesday, February 26th. They set a "buy" rating and a $175.00 target price on the stock. Robert W. Baird reaffirmed a "neutral" rating and set a $137.00 target price (down previously from $153.00) on shares of Tenet Healthcare in a research report on Tuesday, April 15th. Royal Bank of Canada increased their target price on Tenet Healthcare from $183.00 to $189.00 and gave the company an "outperform" rating in a research report on Wednesday. Baird R W lowered Tenet Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Finally, Barclays increased their price objective on Tenet Healthcare from $161.00 to $171.00 and gave the company an "overweight" rating in a report on Wednesday. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, Tenet Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $167.06.

Tenet Healthcare Trading Up 2.4 %

NYSE:THC traded up $3.37 during midday trading on Monday, hitting $146.32. The stock had a trading volume of 973,456 shares, compared to its average volume of 1,544,884. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25. The company has a market capitalization of $13.81 billion, a price-to-earnings ratio of 4.54, a PEG ratio of 1.02 and a beta of 1.77. The stock has a 50-day moving average of $126.55 and a 200 day moving average of $136.62. Tenet Healthcare has a one year low of $109.82 and a one year high of $171.20.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of THC. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA purchased a new position in shares of Tenet Healthcare during the 1st quarter worth $26,000. Wayfinding Financial LLC acquired a new stake in shares of Tenet Healthcare during the 1st quarter worth about $28,000. Colonial Trust Co SC increased its position in shares of Tenet Healthcare by 85.7% during the 4th quarter. Colonial Trust Co SC now owns 247 shares of the company's stock worth $31,000 after purchasing an additional 114 shares during the last quarter. GeoWealth Management LLC increased its position in shares of Tenet Healthcare by 39.8% during the 4th quarter. GeoWealth Management LLC now owns 295 shares of the company's stock worth $37,000 after purchasing an additional 84 shares during the last quarter. Finally, WR Wealth Planners LLC increased its position in shares of Tenet Healthcare by 2,836.4% during the 4th quarter. WR Wealth Planners LLC now owns 323 shares of the company's stock worth $41,000 after purchasing an additional 312 shares during the last quarter. Hedge funds and other institutional investors own 95.44% of the company's stock.

Insider Transactions at Tenet Healthcare

In other news, Director J Robert Kerrey sold 9,525 shares of Tenet Healthcare stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the transaction, the director now owns 27,378 shares in the company, valued at $3,434,022.54. The trade was a 25.81 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.81% of the company's stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.